← Leaderboards
Adam David Kennedy
Baebies, Inc.
$1,036,672
Attributed
$1,036,672
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $440.7K · FY2019–24$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,036,672 · 4
By mechanism
R44$739,006 · 3
R43$297,666 · 1
Top collaborators
No co-investigators on record.
Most similar at Baebies, Inc.
Same institution · by research overlap
- Rajendra Singh$3,079,363
- Jennifer Elderbroom$1,448,584
Others in their field
Other Emerging Leaders on “Laboratories”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$463,311,620
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$210,784,687
- Lynn Briscoe · Leidos Biomedical Research, Inc.$172,823,180
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Leonard Freedmand · Leidos Biomedical Research, Inc.$105,458,370
Research focus
LaboratoriesScreeningSamplingGuidelinesSerumBiochemicalIncidenceHealth StatusInnovationDigitalGenomeCollectionHigh Pressure Liquid ChromatographyHospitalsEnvironmentBiomarker SignatureBiologyBirthAffectCollaborationsDiagnosisDiagnosticFollow-UpBiological
Grant awards (4)
A metabolomics-based laboratory developed test to better predict and monitor progression of type 1 diabetes$298,264
R44 · FY2024 · DK · contact PI
A metabolomics-based laboratory developed test to improve the diagnostic precision of Polycystic Ovary Syndrome$297,666
R43 · FY2023 · HD · contact PI
A Novel Workflow to Screen for Illicit Drug Exposure in Newborns$224,999
R44 · FY2019 · DA · contact PI
An Innovative Unbound Bilirubin Assay to Identify Bilirubin-Induced Neurological Dysfunction (BIND) Risk as Part of a Comprehensive and Novel Point-of-Care Newborn Screening Panel$215,743
R44 · FY2019 · HL · contact PI